Trulieve Announces December 2022 Event Participation

Rhea-AI Summary

Trulieve Cannabis Corp. (OTCQX: TCNNF) announced its participation in several key conferences in December 2022, aimed at enhancing investor engagement. Kim Rivers, CEO, will take part in discussions at the Cowen 5th Annual Cannabis Conference on December 6 and the Arcview Access Cannabis Investment Summit on December 8. Steve White, President, will represent the company at the Stifel 3rd Annual Future of Healthcare Conference on December 7. These events are part of Trulieve's strategy to strengthen its market presence and stakeholder relationships.

Positive

• Participation in major industry conferences can enhance brand visibility and investor relations.
• Trulieve is recognized as a leading cannabis company with established market positions in multiple states.

Negative

• None.

TALLAHASSEE, Fla., Dec. 1, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned participation in upcoming conferences and events in December.

• Cowen 5^th Annual Cannabis Conference, December 6, 2022: Founder and CEO Kim Rivers will participate in a panel discussion and investor meetings.
• Stifel 3^rd Annual Future of Healthcare Conference, December 7, 2022: President Steve White will participate in a panel discussion.
• Arcview Access Cannabis Investment Summit, December 8, 2022: Founder and CEO Kim Rivers will participate in a panel discussion.

Information about our events, links to events where available, and slide presentations can be found at: https://investors.trulieve.com/events-presentations

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_ 
Twitter: @Trulieve 

Investor Contact
Christine Hersey, Executive Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-december-2022-event-participation-301690946.html

SOURCE Trulieve Cannabis Corp.

FAQ

What events is Trulieve participating in December 2022?

Trulieve will participate in the Cowen 5th Annual Cannabis Conference on December 6, the Stifel 3rd Annual Future of Healthcare Conference on December 7, and the Arcview Access Cannabis Investment Summit on December 8.

Who represents Trulieve at the Cowen Cannabis Conference?

CEO Kim Rivers will participate in the panel discussion at the Cowen 5th Annual Cannabis Conference.

What is the stock symbol for Trulieve?

Trulieve trades on the OTCQX market under the symbol TCNNF.

How is Trulieve positioned in the cannabis industry?

Trulieve is a leading vertically integrated cannabis company with strong market positions in states like Arizona, Florida, and Pennsylvania.